Atlas Trials

Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal

Clinical trial NCT05050825 · UNKNOWN

Trial details

NCT number
NCT05050825
Sponsor
Foundation for Innovative New Diagnostics, Switzerland
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
MalariaDengueInfluenza -Like IllnessDiarrheaPneumoniaAcute Febrile Illness
Start date
2021-05-03
Primary completion
2021-11-30
Enrollment
470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.